Ms Z. Liu

Research Fellow

Public Health, Epidemiology and Biostatistics

Contact details

Primary Care, Public Health, Epidemiology and Biostatistics
School of Health and Population Sciences
College of Medical and Dental Sciences
University of Birmingham
Edgbaston
Birmingham
B15 2TT
UK

About

Z. Liu is a Research Fellow in Systmetic Review and Evidence Based Healthcare.

Qualifications

  • MSc Health Technology Assessment 2005
  • Bachelor of Medicine 1990

Teaching

Research

Systematic Review; Health Technology Assessment; Evidence Synthesis

Publications

G Rogers, M Hoyle, J Thompson Coon, T Moxham, Liu Z, Pitt M, K Stein. Dasatinib and nilotinib for imatinib-resistant or-intolerant chronic myeloid leukaemia: a systematic review and economic evaluation. Health Technology Assessment 2012;16 (22):1366–5278

Hoyle M, Rogers G, Moxham T, Liu Z, Stein K. Cost-effectiveness of dasatinib and nilotinib for imatinib-resistant or -intolerant chronic phase chronic myeloid leukemia. Value in Health 2011;14(8):1057–1067

Malottki K, Barton P, Tsourapas A, Uthman AO, Liu Z, Routh K, et al. Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a TNF inhibitor: a systematic review and economic evaluation. Health Technology Assessment 2011;15(14).

Thompson Coon J, Hoyle M, Green C, Liu Z, Welch K, Moxham T, et al. Bevacizumab, sorafenib tosylate and sunitinib for renal cell carcinoma: a systematic review and economic evaluation. Health Technology Assessment 2010;14(2).

Hoyle M, Green C, Thompson-Coon J, Liu Z, Welch K, Moxham T and Stein K. Cost effectiveness of sorafenib for second line treatment of advanced renal cell carcinoma. Value in Health 2010;13:55–60.

Hoyle M, Green C, Thompson Coon J, Liu Z, Welch K, Moxham T, Stein K. Cost-effectiveness of temsirolimus for first line treatment of advanced renal cell carcinoma. Value in Health 2010;13(1):61–68.

Thompson Coon J S, Liu Z, Hoyle M, Rogers G, Green C, Moxham T, Welch K, and Stein K. Reply: SUN vs BEVþIFN in first-line mRCC therapy: no evidence for a statistically significant difference in progression-free survival. British Journal of Cancer 2010 January 5;102(1):234–235.

Thompson-Coon J, Liu Z, Hoyle M, Rogers G, Green C, Moxham T, Welch K, Stein K. Sunitinib and bevacizumab for first line treatment of metastatic renal cell carcinoma: a systematic review and indirect comparison of clinical effectiveness. British Journal of Cancer 2009;101 (2):238–243.

Bond M, Mealing S, Anderson R, Elston J, Weiner G, Taylor RS, Hoyle M, Liu Z, Price A, Stein K. The effectiveness and cost-effectiveness of cochlear implants for severe to profound deafness in children and adults: a systematic review and economic model. Health Technology Assessment 2009;13(44).

Main C, Shepherd J, Anderson R, Rogers G, Thompson-Coon J, Liu Z, Hartwell D, Loveman E, Green C, Pitt M, Stein K, Harris P, Frampton GK, Smith M, Takeda A, Price A, Welch K and Somerville M. Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in children under the age of 12 years. Health Technology Assessment 2008; 12(20).

Shepherd J, Rogers G, Anderson R, Main C, Thompson-Coon J, Hartwell D, Liu Z, Loveman E, Green C, Pitt M, Stein K, Harris P, Frampton GK, Smith M, Takeda A, Price A, Welch K and Somerville M. Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over. Health Technology Assessment 2008; 12(19).

Connock M, Juarez-Garcia A , Jowett S , Frew E , Liu Z , Taylor RJ , Fry-Smith A , Day E , Lintzeris N , Roberts T , Burls A and Taylor RS . Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation. Health Technology Assessment 2007; 11(9).


Liu Z
, Xiong T, Meads C. Clinical effectiveness of treatment with hyperbaric oxygen for neonatal hypoxic-ischaemic encephalopathy: systematic review of Chinese literature. British Medical Journal 2006;333:374.


Liu Z
, Albon E, Hyde C. The effectiveness and cost effectiveness of immunoglobulin replacement therapy for primary immunodeficiency and chronic lymphocytic leukaemia: A systematic review and economic evaluation. DPHE Report No. 54. ISBN: 07044 25793. Birmingham, UK: West Midlands Health Technology Assessment Collaboration, Department of Public Health and Epidemiology, University of Birmingham; 2005. (URL: http://www.rep.bham.ac.uk/reports_list.shtml).

Back to top